Literature DB >> 15557801

Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation?

Alan K Meeker1, Pedram Argani.   

Abstract

Chromosomal instability appears early during breast carcinogenesis and is considered a major driving force in malignant transformation. While current evidence suggests that centrosomal and mitotic checkpoint defects may, in large part, account for numerical chromosomal abnormalities, the mechanisms underlying structural chromosomal abnormalities remain largely unknown. Telomeres stabilize and protect chromosomal termini, but shorten due to cell division and oxidative damage. Moderate telomere shortening signals a tumor suppressive growth arrest in normal cells. Critically short telomeres, in the setting of abrogated DNA damage checkpoints, cause chromosomal instability due to end-to-end chromosomal fusions, subsequent breakage, and rearrangement, resulting in an increased cancer incidence in animal models. Recent results from high resolution in situ telomere length assessment in human breast tissues indicate that significant telomere shortening is prevalent in preinvasive breast lesions (DCIS), as well as focal areas of histologically normal epithelium from which breast carcinoma is thought to arise. Telomere shortening is therefore a strong candidate for the cause of structural chromosome defects that contribute to breast cancer development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557801     DOI: 10.1023/B:JOMG.0000048775.04140.92

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  75 in total

1.  Stabilization of telomere length and karyotypic stability are directly correlated with the level of hTERT gene expression in primary fibroblasts.

Authors:  Wei Cui; Samena Aslam; Judy Fletcher; Diana Wylie; Michael Clinton; A John Clark
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

2.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

3.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

Authors:  Charles R Holst; Gerard J Nuovo; Manel Esteller; Karen Chew; Stephen B Baylin; James G Herman; Thea D Tlsty
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

4.  Telomerase activity and its inhibition in benign and malignant breast lesions.

Authors:  T Sugino; K Yoshida; J Bolodeoku; D Tarin; S Goodison
Journal:  J Pathol       Date:  1997-09       Impact factor: 7.996

5.  Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma.

Authors:  J K Griffith; J E Bryant; C A Fordyce; F D Gilliland; N E Joste; R K Moyzis
Journal:  Breast Cancer Res Treat       Date:  1999-03       Impact factor: 4.872

6.  Telomerase activity and lymphovascular invasion in breast cancer.

Authors:  K M Mokbel; C N Parris; M Ghilchik; C N Amerasinghe; R F Newbold
Journal:  Eur J Surg Oncol       Date:  2000-02       Impact factor: 4.424

7.  Telomerase activity and survival of patients with node-positive breast cancer.

Authors:  G M Clark; C K Osborne; D Levitt; F Wu; N W Kim
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

8.  Delivering antisense telomerase RNA by a hybrid adenovirus/ adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells.

Authors:  Xiaowei Zhang; Zhong Chen; Yanling Chen; Tanjun Tong
Journal:  Oncogene       Date:  2003-04-24       Impact factor: 9.867

9.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes.

Authors:  Rónán C O'Hagan; Sandy Chang; Richard S Maser; Ramya Mohan; Steven E Artandi; Lynda Chin; Ronald A DePinho
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

Review 10.  Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells.

Authors:  Paul Yaswen; Martha R Stampfer
Journal:  Int J Biochem Cell Biol       Date:  2002-11       Impact factor: 5.085

View more
  44 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.

Authors:  Elisabetta Kuhn; Alan Meeker; Tian-Li Wang; Ann Smith Sehdev; Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

Review 3.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

4.  Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.

Authors:  Andrew J Pellatt; Roger K Wolff; Gabriela Torres-Mejia; Esther M John; Jennifer S Herrick; Abbie Lundgreen; Kathy B Baumgartner; Anna R Giuliano; Lisa M Hines; Laura Fejerman; Richard Cawthon; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2013-04-30       Impact factor: 5.006

Review 5.  Cancer telomeres and white crows.

Authors:  Alan K Meeker
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

6.  Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Authors:  Debra Lyon; Lynne Elmore; Noran Aboalela; Jacqueline Merrill-Schools; Nancy McCain; Angela Starkweather; R K Elswick; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2013-04-11       Impact factor: 2.522

7.  Multiple genetic variants in telomere pathway genes and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Hui-Chen Wu; Mary Beth Terry; Qiao Wang; Patrick T Bradshaw; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

8.  Genomic instability demonstrates similarity between DCIS and invasive carcinomas.

Authors:  Christopher M Heaphy; Marco Bisoffi; Nancy E Joste; Kathy B Baumgartner; Richard N Baumgartner; Jeffrey K Griffith
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

Review 9.  The role of telomere biology in bone marrow failure and other disorders.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Mech Ageing Dev       Date:  2007-11-19       Impact factor: 5.432

10.  Telomere length, oxidative damage, antioxidants and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Mary Beth Terry; Qiao Wang; Patrick Bradshaw; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.